← Company intelligence
Robot maker · registered
Biobot Surgical
Mona Lisa is a robot-guided transperineal prostate-biopsy platform: MRI-ultrasound fusion imaging drives robotic needle targeting for precision biopsy and focal therapy, shifting procedures from hospital ORs toward ambulatory and office settings; 50+ real-world clinical publications back the targeting accuracy.
HeadquartersSingapore, SG
Founded2007
Corporate funding$33M
Team51-100
Deployments1
Open roles0
01
Company overview
Identity and operating footprint
Company typeRobot maker
Market segmentCorporate
StageGrowth
FoundersNg Wan Sing (Co-founder)
Regions servedAsia-Pacific, Europe, North America
Countries deployedSG, AU, CN, IT, DE, GB
Service footprintNot listed
Last reviewed2026-07-05
LinkedInView profile
MX
Robot models
Specifications remain vendor-claimed
Machinemedical
Mona Lisa
- Robot-assisted MRI/US-fusion transperineal targeted prostate biopsy with robotic needle guidance; FDA, NMPA, TGA and HSA cleared; 80+ systems, 30,000+ patients
vendor/investor-stated capabilities and install base at the June 2026 round
Claim source
DP
Deployment log
Announced and cited only
CA
Funding history
Publicly announced rounds
Growth
Round sourceSeries B
Investors undisclosed
Round sourceInvestors on recordClavystBioZIG Ventures
TL
Company timeline
Milestones and announcements
2026-06-30S$20M (US$15.4M) growth round led by ClavystBio with ZIG Ventures to fund US expansionDealStreetAsia
2026-06-30Singapore's Biobot Surgical raises $15M to expand robotic prostate cancer platform into US market ↗
2026-02-01First European clinical experience with Mona Lisa 2.0 robot-assisted MRI/US transperineal targeted prostate biopsy published in Prostate Cancer and Prostatic DiseasesNature / Prostate Cancer and Prostatic Diseases
SC
Source ledger
6 unique public sources
01
Biobot Surgical Raises $20 Million led by ClavystBio and supported by ZIG VenturesClavystBio · retrieved 2026-07-05
02Singapore's Biobot Surgical raises $15M to expand robotic prostate cancer platform into US marketTNGlobal · retrieved 2026-07-05
03BIOBOT SUCCESSFULLY CLOSES S$24 MM SERIES B FUNDING ROUNDPR Newswire · retrieved 2026-07-05
04UAB receives cutting-edge robot to diagnose and support treatment of prostate cancerEurekAlert · retrieved 2026-07-05
05Singapore's Biobot Surgical raises $15.5m in funding led by ClavystBioDealStreetAsia · retrieved 2026-07-05
06Robot-assisted MRI/US transperineal target prostate biopsy with Biobot Mona Lisa 2.0: first experience in EuropeNature / Prostate Cancer and Prostatic Diseases · retrieved 2026-07-05